As a technicality, it seems BioStratum is investigating pyridoxamine (as opposed to pyridoxine) for a particular intended use. Their high-priced lawyers are evidently saying others who wish to market pyridoxamine for that intended use can take a hike....to Leavenworth.
Yes, it does look that way doesn’t it.